NASHUA, N.H., July 21 /PRNewswire-FirstCall/ -- iCAD(R), Inc. , an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that Kenneth Ferry, President and CEO of iCAD, Inc., will discuss the Company’s results for the quarter ended June 30, 2006, during a conference call scheduled for Thursday, July 27, 2006, at 11:00am ET. The Company’s financial results for the second quarter are scheduled to be released earlier that day.
Shareholders and other interested parties may participate in the conference call by dialing +1 866 277 1182 (domestic) or +1 617 597 5359 (international) and entering passcode 38515264, a few minutes before 11:00am ET on July 27, 2006. The call will also be broadcast live on the Internet at http://www.streetevents.com, http://www.fulldisclosure.com or http://www.icadmed.com.
A replay of the conference call will be accessible two hours after its completion through August 3, 2006 by dialing +1 888 286 8010 (domestic) or +1 617 801 6888 (international) and entering passcode 81736035. The call will also be archived for 90 days at http://www.streetevents.com, http://www.fulldisclosure.com and http://www.icadmed.com.
About iCAD, Inc.
iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to identify cancer and other life-threatening conditions earlier by making medical services more effective, more accessible and more affordable for patients worldwide. Recipient of Frost & Sullivan’s Growth Strategy Leadership award, iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over fifteen hundred women’s healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com.
iCAD is a registered trademarks of iCAD, Inc.
For iCAD investor relations, contact Kevin McGrath of Cameron Associates at +1 212 245 4577 or via email at kevin@cameronassoc.com.
iCAD, Inc.
CONTACT: Kevin McGrath of Cameron Associates (investor relations),+1-212-245-4577, kevin@cameronassoc.com
Web site: http://www.icadmed.com/
